WOMEN IN CLINICAL-TRIALS

Authors
GERARDCOUE MJ BREART G SPRIET A DEMAREZ JP ADAM G BECHTEL P DEBROSSIAN J BELORGAYBISMUTH C BERDAI D BOISSEL JP CHAUVENET M DAMASSEMICHEL C FOUCHARD F GARREAU M GIRRE JP LEBRUNVIGNES B MUNOZ A PICOT G PUECH A RICHARD E SALVETAT I THIERCELIN JF UZAN S
Citation
Mj. Gerardcoue et al., WOMEN IN CLINICAL-TRIALS, Therapie, 50(4), 1995, pp. 363-368
Citations number
33
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
Therapie → ACNP
ISSN journal
00405957
Volume
50
Issue
4
Year of publication
1995
Pages
363 - 368
Database
ISI
SICI code
0040-5957(1995)50:4<363:WIC>2.0.ZU;2-F
Abstract
In a workshop held in Giens in September 1994, representatives of drug companies and scientists met to discuss the place of women in clinica l trials. They recommend that, in phase II and III studies, men and wo men should be included in a proportion equivalent to that observed for the condition studied. They also recommend that the impact of the gen der on the results should be systematically studied.